Autonomix Medical (AMIX) News Today $11.66 +2.09 (+21.84%) (As of 11/15/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street TipRanks The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 Time Period Autonomix reports Q2 incurred net losses $2.8M vs $6M last yearNovember 12, 2024 | markets.businessinsider.comAutonomix Medical, Inc. Reports Second Quarter Fiscal Year 2025 Financial Results and Provides a Corporate UpdateNovember 11, 2024 | globenewswire.comAutonomix Medical Shares Rise After Positive Trial for Pancreatic Cancer Pain TreatmentNovember 1, 2024 | marketwatch.comAutonomix reports results from first 15 patients’ data on transvascular energyNovember 1, 2024 | msn.comAutonomix participates in Virtual Investor ‘What This Means’ segmentOctober 31, 2024 | markets.businessinsider.comAutonomix Medical, Inc.'s Dr. Robert Schwartz Discusses What Positive 4-6 Week Follow-Up Data Means from Lead-In Patients in Ongoing Human Clinical TrialOctober 30, 2024 | globenewswire.comAutonomix Medical Inc trading resumesOctober 28, 2024 | markets.businessinsider.comAutonomix Medical Inc trading halted, volatility trading pauseOctober 28, 2024 | markets.businessinsider.comAutonomix Shares Soar 85% on Results From Pain-Management StudyOctober 28, 2024 | marketwatch.comWhy Is Nao-Cap Neurology Focused Autonomix Medical Stock Trading Higher On Monday?October 28, 2024 | benzinga.comCrude Oil Tumbles Over 5%; Autonomix Medical Shares Spike HigherOctober 28, 2024 | benzinga.comAutonomix Medical, Inc. (NASDAQ:AMIX) Sees Large Drop in Short InterestAutonomix Medical, Inc. (NASDAQ:AMIX - Get Free Report) was the recipient of a large decline in short interest during the month of October. As of October 15th, there was short interest totalling 136,100 shares, a decline of 23.7% from the September 30th total of 178,400 shares. Based on an average trading volume of 420,800 shares, the days-to-cover ratio is currently 0.3 days. Currently, 1.1% of the company's shares are sold short.October 27, 2024 | marketbeat.comAutonomix Medical, Inc. to Participate in a Virtual Investor “What This Means” Segment on Wednesday, October 30thOctober 25, 2024 | globenewswire.comAutonomix Medical Inc trading halted, news pendingOctober 25, 2024 | markets.businessinsider.comAutonomix Announces 1-for-20 Reverse Stock SplitOctober 22, 2024 | markets.businessinsider.comAutonomix Announces Reverse Stock SplitOctober 22, 2024 | globenewswire.comAutonomix Medical, Inc. to Participate in the 2024 Healthcare Virtual Summit, Presented by Maxim Group LLCOctober 8, 2024 | globenewswire.comAutonomix Medical (NASDAQ:AMIX) Stock Quotes, Forecast and News SummaryOctober 5, 2024 | benzinga.comThis Company Is Taking An Innovative, Non-Opioid Approach To Pain Management For Pancreatic CancerOctober 4, 2024 | finance.yahoo.comAutonomix Flat on Unveiling Corner SegmentSeptember 26, 2024 | baystreet.caAutonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner SegmentSeptember 26, 2024 | globenewswire.comAutonomix Selected to Present at the 2024 Octane Medical Innovation ForumSeptember 20, 2024 | globenewswire.comAutonomix Medical, Inc. to Present at H.C. Wainwright 26th Annual Global Investment ConferenceAugust 27, 2024 | globenewswire.comAutonomix Medical, Inc. Announces Abstract Accepted for Podium Presentation at the 2024 CIRSE Annual CongressAugust 21, 2024 | globenewswire.comAMIX Stock Earnings: Autonomix Medical Reported Results for Q1 2025August 14, 2024 | markets.businessinsider.comAutonomix Medical, Inc. Reports First Quarter Fiscal Year 2025 Financial Results and Reiterates Near-Term MilestonesAugust 13, 2024 | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) Announces Release of the Next CEO Corner SegmentAugust 2, 2024 | globenewswire.comAutonomix Completes Licensing Transaction for FDA-Cleared Ablation TechnologyJuly 24, 2024 | finance.yahoo.comAutonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell SeriesJuly 22, 2024 | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) Participates in Virtual Investor “What This Means” Segment Covering Technology License AgreementJuly 18, 2024 | globenewswire.comWhy Is Autonomix Medical (AMIX) Stock Down 17% Today?July 16, 2024 | investorplace.comWhy Is Autonomix Medical (AMIX) Stock Up 120% Today?July 15, 2024 | investorplace.comAutonomix Medical, Inc. (NASDAQ: AMIX) Reviews Positive Results Seen in Pancreatic Cancer Pain Trial in Virtual Investor “What This Means” SegmentJuly 3, 2024 | globenewswire.comAutonomix Enhances Executive Leadership Team with Appointment of Proven Medical Technology Leader, Brad Hauser, as President and Chief Executive OfficerJune 17, 2024 | globenewswire.comAMIX Stock Earnings: Autonomix Medical Reported Results for Q4 2024June 3, 2024 | investorplace.comAutonomix Announces Approval of Protocol Amendment by Ethics Committee Upon Completion of All Lead-In Patients in Ongoing Human Clinical TrialJune 3, 2024 | globenewswire.comAutonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate UpdateMay 31, 2024 | globenewswire.comAutonomix Medical, Inc. (AMIX)May 24, 2024 | finance.yahoo.comAutonomix Preclinical Study Successfully Demonstrates That Nerve Ablation Can Slow Tumor Metastasis in Pancreatic CancerMay 23, 2024 | globenewswire.comAutonomix Medical, Inc. (NASDAQ: AMIX) to Participate in the Virtual Investor Closing Bell SeriesMay 14, 2024 | globenewswire.comTrading was temporarily halted for "AMIX" at 09:05 AM with a stated reason of "LULD pause."May 7, 2024 | marketbeat.comAMIX Autonomix Medical, Inc.May 5, 2024 | seekingalpha.comAutonomix Enters into Agreement with NoiseFigure Research, Inc. to Develop Next Generation of its Proprietary MicrochipApril 25, 2024 | finance.yahoo.comAutonomix to Present at LIVE! with Webull Corporate Connect: Virtual Biotech Investment WebinarApril 24, 2024 | globenewswire.comAutonomix Announces Issuance of U.S. Patent Covering Proprietary Catheter-Based Technology for the Treatment of Cancer Related PainApril 16, 2024 | globenewswire.comAutonomix Medical Inc. Covered in Benzinga Article Highlighting Innovative Nerve Treatment TechnologyApril 15, 2024 | finance.yahoo.comAutonomix Medical (NASDAQ: AMIX) Is Cracking the Code Of The Peripheral Nervous System With Its Breakthrough Technology To Treat DiseasesApril 11, 2024 | benzinga.comAutonomix Medical's study shows promise in renal treatmentApril 11, 2024 | uk.investing.comAutonomix Announces Positive Findings from Preclinical Study Demonstrating Potential to Improve Renal DenervationApril 9, 2024 | globenewswire.comAutonomix to Participate in the Virtual Investor Lunch Break: The Team Behind the AMIX TickerApril 8, 2024 | globenewswire.com Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Stocks that could triple in a week (Ad)Robinhood traders have piled $78 billion into this market... Driving tiny tech stock gains of 3,000%, 8,942%, and 12,592% in 2020. Now their next one could be here. Click here to pay just $5 for a full year of Stealth Trades AMIX Media Mentions By Week AMIX Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. AMIX News Sentiment▼0.520.57▲Average Medical News Sentiment AMIX News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. AMIX Articles This Week▼41▲AMIX Articles Average Week Get Autonomix Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for AMIX and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Nutriband News Today Milestone Scientific News Today Cytosorbents News Today Bellevue Life Sciences Acquisition News Today CollPlant Biotechnologies News Today Apyx Medical News Today iCAD News Today Envoy Medical News Today Outset Medical News Today Co-Diagnostics News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:AMIX) was last updated on 11/17/2024 by MarketBeat.com Staff From Our PartnersBill Gates’s Next Big AI Bet: StargateIn February 2016… when almost nobody was talking about artificial intelligence…. I picked Nvidia as one of ...Brownstone Research | SponsoredThere is a little known company that is changing warfareWith geo - political instability around the world investors are flocking to defense contract stocks. There...Reticulate | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredElon knows the truth, which is why they want him silencedElon Musk is one of mankind’s greatest innovators. But for all his visionary prowess and contributions to h...Porter & Company | SponsoredTrump Wins… But Elon Says Get Ready to BraceTrump's back in the White House, ready to hit the gas on America's comeback. He's taking on the economy wi...Genesis Gold Group | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | SponsoredBut another coin could soar even higher …Donald Trump wants to be America’s first crypto president. He was the keynote speaker at the recent Bitcoin co...Weiss Ratings | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Autonomix Medical, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Autonomix Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
